232 related articles for article (PubMed ID: 24890344)
1. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.
Matikainen N; Adiels M; Söderlund S; Stennabb S; Ahola T; Hakkarainen A; Borén J; Taskinen MR
Obesity (Silver Spring); 2014 Aug; 22(8):1854-9. PubMed ID: 24890344
[TBL] [Abstract][Full Text] [Related]
2. Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.
Pramfalk C; Pavlides M; Banerjee R; McNeil CA; Neubauer S; Karpe F; Hodson L
J Clin Endocrinol Metab; 2015 Dec; 100(12):4425-33. PubMed ID: 26414963
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans.
Steenson S; Shojaee-Moradie F; B Whyte M; G Jackson K; Lovegrove JA; A Fielding B; Umpleby AM
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32549314
[TBL] [Abstract][Full Text] [Related]
4. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
5. Postprandial lipemia associates with liver fat content.
Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
[TBL] [Abstract][Full Text] [Related]
6. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.
Matikainen N; Taskinen MR; Stennabb S; Lundbom N; Hakkarainen A; Vaaralahti K; Raivio T
Eur J Endocrinol; 2012 Mar; 166(3):487-92. PubMed ID: 22190000
[TBL] [Abstract][Full Text] [Related]
7. Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects.
Taskinen MR; Björnson E; Andersson L; Kahri J; Porthan K; Matikainen N; Söderlund S; Pietiläinen K; Hakkarainen A; Lundbom N; Nilsson R; Ståhlman M; Adiels M; Parini P; Packard C; Borén J
J Clin Lipidol; 2020; 14(1):77-87. PubMed ID: 31917184
[TBL] [Abstract][Full Text] [Related]
8. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
9. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.
Haidari M; Leung N; Mahbub F; Uffelman KD; Kohen-Avramoglu R; Lewis GF; Adeli K
J Biol Chem; 2002 Aug; 277(35):31646-55. PubMed ID: 12070142
[TBL] [Abstract][Full Text] [Related]
10. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women.
Mekki N; Christofilis MA; Charbonnier M; Atlan-Gepner C; Defoort C; Juhel C; Borel P; Portugal H; Pauli AM; Vialettes B; Lairon D
J Clin Endocrinol Metab; 1999 Jan; 84(1):184-91. PubMed ID: 9920081
[TBL] [Abstract][Full Text] [Related]
11. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome.
Tushuizen ME; Pouwels PJ; Bontemps S; Rustemeijer C; Matikainen N; Heine RJ; Taskinen MR; Diamant M
Atherosclerosis; 2010 Jul; 211(1):308-14. PubMed ID: 20227695
[TBL] [Abstract][Full Text] [Related]
12. Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins.
Couillard C; Bergeron N; Pascot A; Alméras N; Bergeron J; Tremblay A; Prud'homme D; Després JP
Am J Clin Nutr; 2002 Aug; 76(2):311-8. PubMed ID: 12145000
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
14. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
[TBL] [Abstract][Full Text] [Related]
15. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men.
Marques-Lopes I; Ansorena D; Astiasaran I; Forga L; Martínez JA
Am J Clin Nutr; 2001 Feb; 73(2):253-61. PubMed ID: 11157321
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
Hamsten A; Silveira A; Boquist S; Tang R; Bond MG; de Faire U; Björkegren J
J Am Coll Cardiol; 2005 Apr; 45(7):1013-7. PubMed ID: 15808756
[TBL] [Abstract][Full Text] [Related]
17. [Preheparin lipoprotein lipase mass and apolipoproteinC-III ratio helps identify postprandial triglyceride metabolic marker].
Miyake N; Miyake K; Higurashi H; Ohsaka A
Rinsho Byori; 2007 Nov; 55(11):1019-24. PubMed ID: 18154034
[TBL] [Abstract][Full Text] [Related]
18. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
19. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
[TBL] [Abstract][Full Text] [Related]
20. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
